Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
about
The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathyHepatitis C virus and neurological damageEvidence from Human and Animal Studies: Pathological Roles of CD8(+) T Cells in Autoimmune Peripheral NeuropathiesImmune Regulation of Antibody Access to Neuronal TissuesMultiple Sites Ultrasonography of Peripheral Nerves in Differentiating Charcot-Marie-Tooth Type 1A from Chronic Inflammatory Demyelinating Polyradiculoneuropathy.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protectionPOEMS syndrome with vascular transformation of the lymph node sinuses: A case report.Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.A special subtype of POEMS syndrome: IgG4 subtypeHuman Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.HCV-related central and peripheral nervous system demyelinating disorders.IgM MGUS associated with anti-MAG neuropathy: a single institution experience.Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy.Ultrasound in the diagnosis of peripheral neuropathy: structure meets function in the neuromuscular clinic.New insights into the management of chronic inflammatory demyelinating polyradiculoneuropathy.Spinal Nerve Root Enhancement on MRI Scans in Children: A Review.Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.Treatment of muscle weakness in neuromuscular disorders.Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.Transmission of Hepatitis B Core Antibody and Galactomannan Enzyme Immunoassay Positivity via Immunoglobulin Products: A Comprehensive Analysis.Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.Ocular Neuromyotonia Associated with Chronic Inflammatory Demyelinating Polyneuropathy.Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDPDADS neuropathy associated with anti-TNF-α therapy.Chronic inflammatory demyelinating polyradiculoneuropathy and anesthesia: a case series.A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy.Changes in spatiotemporal gait parameters following intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.CIDP presenting as recurrent severe back pain without weakness or sensory loss.Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes.Nerve enlargement in an unusual case of inflammatory neuropathy and new gene mutation-morphology is the key.Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.Diagnostic insights into chronic-inflammatory demyelinating polyneuropathiesAssociation of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis
P2860
Q26743993-AF3EDB67-D353-4A4B-A18A-7E565347A028Q26748575-CEE67BA1-66FF-44BE-9F56-8302B95BCD70Q26777185-3E8F45B3-3AD9-49CD-9B73-2354C3AFB23EQ28733365-CDDA1947-495F-4F7B-986D-B5D0D0DA30C9Q29994832-BB4684FB-CE6C-4F22-9C86-C953E512DD3EQ30276550-27DC9D51-69CD-496A-9F69-FB114685F82AQ33608864-EBF338DD-E9D5-4129-A02D-FFC896307FCBQ35943126-DDD2BE38-9F7B-40F0-845E-1A799BA3CBB9Q36691991-8128CCA5-98EB-4CAC-A4C3-2DB793FAC7A4Q36841176-E83A7266-A942-4873-8E04-8FC6FB3CA59CQ36869897-83418C48-D450-4721-B2A0-20937B4549F2Q38246873-32C62AF5-0800-49DE-A8EC-99C5EABE9556Q38311759-AA8A1B04-B2DB-4FEF-82B6-1D3936918CCFQ38334722-6D010A30-B8A4-4853-B65B-EAD7F42C9A87Q38344766-FFB5D20D-5E4C-43EA-8426-D43DCA6EA846Q38536776-32C18D37-9884-4905-BA2F-A826670EA8F1Q38586026-190BF7C0-2425-48AA-B5CF-E34A1062993CQ38590743-A7961AFC-49AD-47A7-8BD6-2DB79BF3A1B3Q38845507-D334C05E-38AF-4045-89ED-7DD130533AEFQ38910047-BEA52741-2561-4B46-9FCD-D39B193F7725Q39434973-FB4C9D6F-1C4B-447E-A327-DF67F8B7ACD7Q40801411-F92FD6AA-AF29-408A-8B1C-A3FFBB15BF02Q41331119-9C6AA353-627E-474F-B2F7-FA53DA67F520Q42241992-2067AD1E-CB82-4682-826A-C1E1A7F78F58Q42290388-E760BF8D-F5C0-4AA0-AED0-61783DE505AAQ45979962-11FEB9A0-3685-4A70-A8BC-E7C29D4D2E3CQ47249593-879DBD88-82FB-48D0-8693-C0BEA8B0288DQ48172357-178CE3D1-7128-4887-AA55-4B34CC513647Q50954501-55DAC06F-BC02-40A4-BDD9-4824699CDA6AQ51698475-68C6BE88-3F3C-4B6B-8FA0-A08CE53BE173Q52806003-E6484F7D-A51C-473C-9E94-741AF2090D35Q52878845-F5590A35-68F4-49A9-80C7-0B75613970FAQ53136730-32AAA813-6013-4A61-A3C6-6596FDDA1DCEQ57300562-340F9A1B-BD12-47F2-89C6-0D4C5E5A8987Q58702983-7AF47754-C1ED-490E-A8BA-AC088D7AF15D
P2860
Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
@en
type
label
Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
@en
prefLabel
Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
@en
P1476
Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
@en
P2093
Norman Latov
P2888
P304
P356
10.1038/NRNEUROL.2014.117
P407
P577
2014-07-01T00:00:00Z
P6179
1047952868